Opioid Prescriber Training Program
The purpose of the New York State (NYS) Prescription Drug Overdose (PDO) Prevention Program is to advance and evaluate comprehensive state-level interventions for preventing prescription drug overuse, misuse, abuse, and overdose.
Category
Format
  • Self-study / Enduring
Credits
  • 2.00 AMA PRA Category 1 Credit™
The Opioid Epidemic: Searching for Solutions Webcast
Learn about opioid use disorder, treatment barriers, and overdose recognition. Discover current and emerging treatment options to improve patient care and outcomes.
Category
Format
  • Self-study / Enduring
  • Webinar recorded
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
Controlled Substances and Substance Abuse: Best Practices for the Healthcare Professional
Learn safe and effective prescription of controlled substances, best-practices, and prevention methods for drug misuse in this course.
Category
Format
  • Self-study / Enduring
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC
Strategies for Appropriate Opioid Prescribing: The Florida APRN/PA Requirement
Opioid analgesic medications can bring substantial relief to patients suffering from pain.
Category
  • Prescribing: Opioid(s)
Format
  • Self-study / Enduring
Credits
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC
Developing a Safe Opioid Treatment Plan for Managing Chronic Pain
Healthcare professionals should know best clinical practices in opioid prescribing, including the associated risks of opioids, approaches to the assessment of pain and function, and pain management modalities.
Category
Format
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit™
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain
The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse.
Category
Format
  • Self-study / Enduring
Credits
  • 3.50 AANP Contact Hours
  • 1.59 AANP Pharmacology Contact Hours
  • 3.50 AMA PRA Category 1 Credit™
Therapeutic Use of KASPER and Urine Drug Screening and Testing in Clinical Practice
Needs Statement
Category
Format
  • Self-study / Enduring
Credits
  • 0.75 AMA PRA Category 1 Credit™